The role of VEGF receptors in angiogenesis; complex partnerships

por Cébe-Suarez, S., Zehnder-Fjällman, A., Ballmer-Hofer, K.
Publicado 2006

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

por Marty, C, Odermatt, B, Schott, H, Neri, D, Ballmer-Hofer, K, Klemenz, R, Schwendener, R A
Publicado 2002

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

por Zeisberger, S M, Odermatt, B, Marty, C, Zehnder-Fjällman, A H M, Ballmer-Hofer, K, Schwendener, R A
Publicado 2006

Diabetes‐induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain

por Ved, N., Da Vitoria Lobo, M. E., Bestall, S. M., L. Vidueira, C., Beazley‐Long, N., Ballmer‐Hofer, K., Hirashima, M., Bates, D. O., Donaldson, L. F., Hulse, R. P.
Publicado 2018

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia()

por Hulse, R.P., Beazley-Long, N., Hua, J., Kennedy, H., Prager, J., Bevan, H., Qiu, Y., Fernandes, E.S., Gammons, M.V., Ballmer-Hofer, K., Gittenberger de Groot, A.C., Churchill, A.J., Harper, S.J., Brain, S.D., Bates, D.O., Donaldson, L.F.
Publicado 2014